Background

Stelliana completed honours at the Burnet Institute in 2016. Her honours project focussed on the relationship between fibrosis and quality of life in people who inject drugs living with hepatitis C virus. She intends to continue a similar line of research, beginning a PhD in 2017 focussing on the effects of hepatitis C treatment on wellbeing.

Qualifications

• 2016: Bachelor of Biomedical Science (Honours), Monash University;
• 2015: Bachelor of Science, University of Melbourne

Awards

• 2017 RTP Stipend, formerly Australian Postgraduate Award

Projects (1)

Current (1)

• Sexual Health And Risk Prevention (SHARP) Study
  Assessing responses to HIV prevention measures among Australian MSM.

Publications (4)

2019 (2)

• "I'm obviously not dying so it's not something I need to sort out today": Considering hepatitis C treatment in the era of direct acting antivirals.
  Wright C, Cogger S, Hsieh K, Goutzamanis S, Hellard M, Higgs P
  Infect Dis Health. 2019 Jan; Epub ahead of print
• Improving hepatitis C direct-acting antiviral access and uptake: a role for patient-reported outcomes and lived-experience.
  Goutzamanis S, Doyle J, Higgs P, Hellard M
  J Viral Hepat. 2019 Jan; 26(2):218-223

2018 (2)

• Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study.
  Goutzamanis S, Doyle JS, Thompson A, Dietze P, Hellard M, Higgs P; TAP study group.
  BMC Infect Dis. 2018 Apr; 18(1):151
• Increasing amphetamine use and forensic involvement among clients of three residential Indigenous alcohol and other drug services in Victoria, Australia.
  Goutzamanis S, Higgs P, Richardson M, MacLean S
  Drug Alcohol Rev. 2018 Mar; Epub ahead of print